Skip to main content
logo
Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.220
-0.050 (-1.17%)
At close: Aug 5, 2026, 4:00 PM EDT
4.220
0.00 (0.00%)
After-hours: Aug 5, 2026, 4:20 PM EDT

Orchestra BioMed Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
32.7233.482.642.763.53-
Revenue Growth
1033.89%1169.22%-4.42%-21.88%--
Gross Profit
32.5533.292.432.573.32-
Operating Income
-54.96-51.81-64.3-51.51-32.66-0.39
Net Income
-54.86-52.96-61.02-49.12-33.61-0.38
Earnings Per Share
-0.97-1.11-1.66-1.48-2.24-2.61
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
94.4106.5166.8187.683.791.75
Total Debt
33.6432.4416.531.6911.870
Net Cash (Debt)
60.7774.0850.2885.9171.921.75
Net Cash Growth
81.71%47.32%-41.47%19.46%3998.98%-13.44%
Net Cash Per Share
1.131.551.372.594.800.20

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-54.52-48.96-50.56-46.13-29.29-0.27
Capital Expenditures
-0.56-0.49-0.29-0.08-0.59-
Free Cash Flow
-55.08-49.45-50.85-46.21-29.88-0.27
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
99.46%99.43%92.27%93.26%94.03%-
Operating Margin
-167.96%-154.73%-2437.49%-1866.16%-924.34%-
Pretax Margin
-167.63%-157.40%-2313.27%-1779.71%-951.26%-
Profit Margin
-167.63%-157.40%-2313.27%-1779.71%-951.26%-
FCF Margin
-168.31%-147.70%-1927.48%-1674.09%-845.74%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
7.727.0757.91118.3531.67-